| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.04 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |